Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02572973 · ClinicalTrials.gov registry record · NA
Acoustic Neuromodulation (ANM) for Youth With Anxiety Disorders
A NA study, sponsored by Weill Medical College of Cornell University.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT02572973: Clinical Trial NA study, sponsored by Weill Medical College of Cornell University.
NCT02572973 is a NA study that was terminated before completion, run by Weill Medical College of Cornell University. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02572973, a NA study, was terminated before completion, sponsored by Weill Medical College of Cornell University.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The acoustic neuromodulation trial (ANM-T) is a two-phase, single-site, pilot randomized clinical trial examining the feasibility of completing a larger scale efficacy study of a novel treatment of non-linear modulated acoustic stimuli to reduce anxiety severity in youth with anxiety disorders. The primary objective is to establish the feasibility of a blinded randomized controlled trial of ANM for childhood anxiety disorders.
Primary Outcome
The ADIS will be measured to to establish the efficacy of ANM to placebo in reducing anxiety symptoms and associated disability.
Interventions
- OTHER Acoustic Neuromodulation (ANM)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2014-07 |
| Est. Completion | 2016-04 |
| Phase | NA |
Why NCT02572973 stopped before completion
NCT02572973 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Acoustic Neuromodulation (ANM) is the first listed.
NCT02572973 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02572973 about?
NCT02572973 is a clinical study titled "Acoustic Neuromodulation (ANM) for Youth With Anxiety Disorders". The acoustic neuromodulation trial (ANM-T) is a two-phase, single-site, pilot randomized clinical trial examining the feasibility of completing a larger scale efficacy study of a novel treatment of non-linear modulated acoustic stimuli to reduce anxiety severity in youth with anxiety disorders. The ...
What is the current status of trial NCT02572973?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2014-07. Estimated completion is 2016-04.
What interventions are being tested in trial NCT02572973?
The interventions under investigation include: Acoustic Neuromodulation (ANM) (OTHER).
Who is sponsoring clinical trial NCT02572973?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02572973's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia